Analysts See $0.02 EPS for CRH Medical Corporation (CRHM)

October 14, 2018 - By Ruchi Gupta

CRH Medical Corporation (NYSEAMERICAN:CRHM) Logo

Analysts expect CRH Medical Corporation (NYSEAMERICAN:CRHM) to report $0.02 EPS on November, 7.They anticipate $0.01 EPS change or 33.33 % from last quarter’s $0.03 EPS. CRHM’s profit would be $1.46 million giving it 43.13 P/E if the $0.02 EPS is correct. After having $0.02 EPS previously, CRH Medical Corporation’s analysts see 0.00 % EPS growth. The stock decreased 0.58% or $0.02 during the last trading session, reaching $3.45. About 36,354 shares traded. CRH Medical Corporation (NYSEAMERICAN:CRHM) has risen 71.43% since October 14, 2017 and is uptrending. It has outperformed by 55.81% the S&P500.

CRH Medical Corporation provides products and services to physicians for the treatment of gastrointestinal diseases in the United States. The company has market cap of $252.23 million. It offers anesthesia services for patients undergoing endoscopic procedures; and CRH O'Regan System, a single use, disposable, and hemorrhoid banding technology for treating hemorrhoid grades I??IV. It has a 31.36 P/E ratio. The firm distributes the CRH O'Regan System, treatment protocols, and operational and marketing expertise as a turnkey package directly to physicians.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>